Is Relapsing-Remitting MS Hereditary? Risk & Testing
At a Glance
Relapsing-remitting MS is not inherited through a single gene. Children and siblings have a higher risk than the general population, but most will never develop MS, so routine genetic testing or MRI scans are not recommended without symptoms.
In this answer
4 sections
Relapsing-remitting multiple sclerosis (RRMS) is not strictly hereditary in the way that eye color or conditions like cystic fibrosis are passed down. Instead, MS is a complex disease associated with a combination of genetic susceptibility and environmental factors [1][2]. While having a parent or sibling with MS does increase a person’s risk compared to the general population, the vast majority of family members will never develop the condition [3][4].
Understanding the Risk for Family Members
MS is a polygenic condition, meaning it involves variations in hundreds of different genes, none of which are strong enough to cause the disease on their own [4]. Because no single gene determines whether someone will get MS, there is no simple inheritance pattern. Family history cannot reliably predict whether a relative would develop relapsing-remitting MS versus a progressive form of the disease.
The risk is higher for first-degree relatives (children, siblings, and parents). Research shows that children and siblings of someone with MS have a higher chance of developing the condition than people with no family history [3][5]. While specific estimates vary widely based on the study, the country, and the sex of the individuals, the absolute risk remains low. Even with an affected parent or sibling, the vast majority of first-degree relatives will not develop MS [6].
The genetic risk is thought to interact with environmental exposures, though the exact causes are not fully understood [1]. Developing MS is no one’s fault, and these environmental factors are simply associated with a higher risk:
- Epstein-Barr virus (EBV): Previous infection with this extremely common virus (which causes mononucleosis) is strongly associated with MS risk, though infection alone is not enough to cause the disease [7].
- Vitamin D and sunlight: Lower levels of vitamin D and low sunlight exposure are observationally linked to a higher risk of developing MS [8][9].
- Smoking: Smoking cigarettes is associated with an increased likelihood of developing MS, especially in people with a genetic susceptibility [10][11].
- Adolescent obesity: Being overweight or obese during childhood and adolescence is another associated risk factor [12][11].
Should My Children or Siblings Be Tested?
Routine predictive testing—whether genetic testing or MRI scans—is not recommended for children or siblings who feel well and do not have symptoms.
- Genetic Testing: Because MS involves hundreds of genes, currently available genetic tests cannot reliably predict who will develop the disease [13]. Knowing a family member’s genetic score would not change their medical management or give a definitive answer about their future health.
- MRI Scans: Routine MRI screening for symptom-free relatives is not established practice. Sometimes, an MRI done for an unrelated reason reveals incidental, MS-like spots in someone with no symptoms—a situation called radiologically isolated syndrome (RIS). RIS is not the same as MS, but discovering it can lead to complex monitoring decisions, debates about early treatment, and unnecessary anxiety [14].
When to Seek Medical Advice
Family members should not have MRIs just because of their family history. However, they should seek a doctor’s evaluation if they develop new, unexplained neurologic symptoms.
- Emergency Symptoms: Sudden weakness, trouble speaking, severe imbalance, or sudden vision loss can be medical emergencies (such as a stroke) and require immediate emergency care. Do not wait to see if they persist.
- Other Symptoms: Symptoms like numbness, tingling, vision changes, or balance problems that last more than 24 hours (without a fever or infection) should be evaluated by a clinician.
It is important to remember that many common, less serious conditions can cause these symptoms, so an unexplained symptom should not automatically be assumed to be MS.
What Family Members Can Do
While there is no guaranteed way to prevent MS, family members can focus on healthy lifestyle choices that are good for general health and address some of the associated environmental risk factors [11]:
- Don’t smoke: Avoid starting, and quit if you currently smoke. This is excellent for overall health and removes a known MS risk association [10].
- Maintain a healthy weight: Encourage a balanced diet and regular exercise to support overall health and help prevent childhood and adolescent obesity [12].
- Discuss nutrition and Vitamin D: Have family members discuss general, age-appropriate nutrition and bone health with their doctor. While low vitamin D is linked to MS, it has not been proven that taking high doses of supplements prevents MS in healthy relatives. Testing or supplementation should only be done when clinically indicated by a doctor [11][9].
Common questions in this guide
Can relapsing-remitting MS be passed from a parent to a child?
Should healthy children or siblings of someone with MS have genetic testing?
Do relatives without symptoms need an MRI to screen for MS?
What symptoms should a family member with MS in the family watch for?
Can lifestyle changes prevent MS in family members?
Related questions
Show more
Get notified when new evidence is published on relapsing-remitting multiple sclerosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (14)
- 1
Familial occurrence of multiple sclerosis - current state of knowledge.
Kubicka-Bączyk K, Bączyk J, Adamczyk-Sowa M
Neurologia i neurochirurgia polska 2026; doi:10.5603/pjnns.112253.
PMID: 42813438 - 2
Genetic Risk in Multiple Sclerosis: Susceptibility, Modifiers and Unresolved Questions.
He J, Blackburn NB, Jokubaitis VG
Neurology and therapy 2026; (15(5)):2301-2320 doi:10.1007/s40120-026-01009-8.
PMID: 42593635 - 3
A Prospective Study of Individuals at Risk of Multiple Sclerosis Informs the Design of Primary Prevention Studies.
Laitinen AW, Tozlu C, Roostaei T, et al.
Annals of clinical and translational neurology 2026; (13(8)):1591-1601 doi:10.1002/acn3.70340.
PMID: 41700751 - 4
Genetics of multiple sclerosis: lessons from polygenicity.
Goris A, Vandebergh M, McCauley JL, et al.
The Lancet. Neurology 2022; (21(9)):830-842 doi:10.1016/S1474-4422(22)00255-1.
PMID: 35963264 - 5
Increasing prevalence of familial recurrence of multiple sclerosis in Iran: a population based study of Tehran registry 1999-2015.
Eskandarieh S, Allahabadi NS, Sadeghi M, Sahraian MA
BMC neurology 2018; (18(1)):15 doi:10.1186/s12883-018-1019-2.
PMID: 29415659 - 6
Epidemiology of familial multiple sclerosis: A population-based study in Tehran during 1999-2018.
Salehi Z, Almasi-Hashiani A, Sahraian MA, Eskandarieh S
Multiple sclerosis and related disorders 2020; (43()):102178 doi:10.1016/j.msard.2020.102178.
PMID: 32417663 - 7
DRB1-environment interactions in multiple sclerosis etiology: results from two Swedish case-control studies.
Hedström AK, Hillert J, Brenner N, et al.
Journal of neurology, neurosurgery, and psychiatry 2021; (92(7)):717-722 doi:10.1136/jnnp-2020-325676.
PMID: 33687974 - 8
Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis.
Olsson T, Barcellos LF, Alfredsson L
Nature reviews. Neurology 2017; (13(1)):25-36 doi:10.1038/nrneurol.2016.187.
PMID: 27934854 - 9
A systematic review of Mendelian randomization studies on multiple sclerosis.
Fazia T, Baldrighi GN, Nova A, Bernardinelli L
The European journal of neuroscience 2023; (58(4)):3172-3194 doi:10.1111/ejn.16088.
PMID: 37463755 - 10
The interaction between smoking and HLA genes in multiple sclerosis: replication and refinement.
Hedström AK, Katsoulis M, Hössjer O, et al.
European journal of epidemiology 2017; (32(10)):909-919 doi:10.1007/s10654-017-0250-2.
PMID: 28597127 - 11
Non-infectious environmental risk factors of multiple sclerosis: Mechanisms and intervention windows for prevention.
Rival M, Thouvenot E
Revue neurologique 2026; (182(5)):455-466 doi:10.1016/j.neurol.2026.03.010.
PMID: 41986183 - 12
Gene-Environment Interactions in Multiple Sclerosis: A UK Biobank Study.
Jacobs BM, Noyce AJ, Bestwick J, et al.
Neurology(R) neuroimmunology & neuroinflammation 2021; (8(4)) doi:10.1212/NXI.0000000000001007.
PMID: 34049995 - 13
A Risk Score for Predicting Multiple Sclerosis.
Dobson R, Ramagopalan S, Topping J, et al.
PloS one 2016; (11(11)):e0164992 doi:10.1371/journal.pone.0164992.
PMID: 27802296 - 14
MRI features associated with high likelihood of conversion of radiologically isolated syndrome to multiple sclerosis.
Bisulca J, De Lury A, Coyle PK, et al.
Multiple sclerosis and related disorders 2019; (36()):101381 doi:10.1016/j.msard.2019.101381.
PMID: 31518773
This page provides general information about family risk and screening for relapsing-remitting MS for informational purposes only and does not constitute medical advice. A clinician should guide testing or evaluation, and sudden weakness, trouble speaking, severe imbalance, or sudden vision loss require emergency care.